Published in Int J Chron Obstruct Pulmon Dis on September 08, 2017
Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med (2009) 35.68
Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med (2010) 15.07
Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax (2002) 8.77
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax (2005) 7.39
Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med (1997) 5.93
Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2000) 5.49
Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2004) 4.87
Temporal clustering of exacerbations in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2008) 4.73
Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. N Engl J Med (1999) 4.66
Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax (2002) 4.26
Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest (2007) 4.21
Course and prognosis of chronic obstructive lung disease. A prospective study of 200 patients. N Engl J Med (1969) 4.09
Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax (2003) 4.02
Short-term and long-term outcomes of moxifloxacin compared to standard antibiotic treatment in acute exacerbations of chronic bronchitis. Chest (2004) 3.25
Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD. Eur Respir J (2012) 2.87
Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest (2007) 2.67
In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease. Arch Intern Med (2003) 2.64
Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. JAMA (2013) 2.59
Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2009) 2.53
Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J (2005) 2.51
The costs of treating COPD in the United States. Chest (2001) 2.43
Factors associated with bronchiectasis in patients with COPD. Chest (2011) 2.14
Unsuspected risk factors of frequent exacerbations requiring hospital admission in chronic obstructive pulmonary disease. Int J Clin Pract (2013) 2.09
Costly hospital readmissions and complex chronic illness. Inquiry (2009) 2.02
Anxiety and depression are related to the outcome of emergency treatment in patients with obstructive pulmonary disease. Chest (2002) 1.95
Inflammatory changes, recovery and recurrence at COPD exacerbation. Eur Respir J (2006) 1.94
Risk factors for lower airway bacterial colonization in chronic bronchitis. Eur Respir J (1999) 1.93
Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis (1992) 1.86
Deaths from chronic obstructive pulmonary disease--United States, 2000-2005. MMWR Morb Mortal Wkly Rep (2008) 1.84
Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results. Eur Respir J (2011) 1.68
Microbiome diversity in the bronchial tracts of patients with chronic obstructive pulmonary disease. J Clin Microbiol (2012) 1.61
Development and validation of a survey-based COPD severity score. Chest (2005) 1.57
Risk factors for hospital readmission in patients with chronic obstructive pulmonary disease. Respiration (2005) 1.56
Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease. J Clin Microbiol (2014) 1.53
Frequent hospital readmissions for acute exacerbation of COPD and their associated factors. Respirology (2006) 1.50
Levofloxacin versus clarithromycin in COPD exacerbation: focus on exacerbation-free interval. Eur Respir J (2004) 1.50
Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population. Int J Chron Obstruct Pulmon Dis (2012) 1.47
Health-related QOL in acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease: a review of the literature. Pharmacoeconomics (2005) 1.42
Exacerbation frequency and course of COPD. Int J Chron Obstruct Pulmon Dis (2012) 1.38
Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2007) 1.38
Predictors of early readmission among patients 40 to 64 years of age hospitalized for chronic obstructive pulmonary disease. Ann Am Thorac Soc (2014) 1.36
Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en Servicios de medicina interna (ESMI) study. Chest (2012) 1.33
Efficacy of oral ciprofloxacin vs. clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group. Clin Infect Dis (1998) 1.31
Exacerbations and lung function decline in COPD: new insights in current and ex-smokers. Respir Med (2006) 1.31
Acute exacerbation of chronic obstructive pulmonary disease: influence of social factors in determining length of hospital stay and readmission rates. Can Respir J (2008) 1.28
Psychosocial risk factors for hospital readmission in COPD patients on early discharge services: a cohort study. BMC Pulm Med (2011) 1.22
Resolution of bronchial inflammation is related to bacterial eradication following treatment of exacerbations of chronic bronchitis. Thorax (2003) 1.20
Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes. Int J Chron Obstruct Pulmon Dis (2009) 1.19
Dyspnoea severity and pneumonia as predictors of in-hospital mortality and early readmission in acute exacerbations of COPD. Thorax (2011) 1.18
Clinical audit of COPD patients requiring hospital admissions in Spain: AUDIPOC study. PLoS One (2012) 1.15
Lessons from ECLIPSE: a review of COPD biomarkers. Thorax (2013) 1.13
Risk assessment of readmissions following an initial COPD-related hospitalization. Int J Chron Obstruct Pulmon Dis (2013) 1.11
Resource use study in COPD (RUSIC): a prospective study to quantify the effects of COPD exacerbations on health care resource use among COPD patients. Can Respir J (2007) 1.09
Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis (2014) 1.02
Prospective multicenter study of relapse following emergency department treatment of COPD exacerbation. Chest (2004) 0.99
Prevalence and risks of chronic airway obstruction: a population cohort study in taiwan. Chest (2007) 0.96
COPD severity score as a predictor of failure in exacerbations of COPD. The ESFERA study. Respir Med (2011) 0.95
Factors affecting chronic obstructive pulmonary disease early rehospitalization. Chron Respir Dis (2012) 0.94
Biomarker Development for Chronic Obstructive Pulmonary Disease. From Discovery to Clinical Implementation. Am J Respir Crit Care Med (2015) 0.92
Cured meat consumption increases risk of readmission in COPD patients. Eur Respir J (2012) 0.91
Global muscle dysfunction as a risk factor of readmission to hospital due to COPD exacerbations. Respir Med (2010) 0.91
Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD Audit. Eur Respir J (2015) 0.87
A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology. Int J Chron Obstruct Pulmon Dis (2011) 0.87
Risk factors of hospitalization and readmission of patients with COPD in Hong Kong population: analysis of hospital admission records. BMC Health Serv Res (2011) 0.86
Malnutrition and obesity: influence in mortality and readmissions in chronic obstructive pulmonary disease patients. J Hum Nutr Diet (2013) 0.85
Predicting In-Hospital Treatment Failure (≤7 days) in Patients with COPD Exacerbation Using Antibiotics and Systemic Steroids. COPD (2015) 0.85
Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis. Eur Respir J (2011) 0.84
Risk factors associated with chronic obstructive pulmonary disease early readmission. Curr Med Res Opin (2013) 0.83
Systemic Corticosteroids in Chronic Obstructive Pulmonary Disease Exacerbations (SCCOPE): rationale and design of an equivalence trial. Veterans Administration Cooperative Trials SCCOPE Study Group. Control Clin Trials (1998) 0.83
Bronchiectasis as a Comorbidity of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. PLoS One (2016) 0.82
The existence of bronchiectasis predicts worse prognosis in patients with COPD. Sci Rep (2015) 0.82
Factors associated with bronchiectasis in patients with moderate-severe chronic obstructive pulmonary disease. Medicine (Baltimore) (2016) 0.81
Importance of noninvasively measured respiratory muscle overload among the causes of hospital readmission of COPD patients. Chest (2008) 0.81
Serum magnesium is an independent predictor of frequent readmissions due to acute exacerbation of chronic obstructive pulmonary disease. Respir Med (2008) 0.80
Readmission for Acute Exacerbation within 30 Days of Discharge Is Associated with a Subsequent Progressive Increase in Mortality Risk in COPD Patients: A Long-Term Observational Study. PLoS One (2016) 0.79
Open-label, randomized comparison trial of long-term outcomes of levofloxacin versus standard antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease. Respirology (2007) 0.79
Burden of Exacerbations in Patients with Moderate to Very Severe COPD in the Netherlands: A Real-life Study. COPD (2014) 0.76
Readmission in COPD patients: should we consider it a marker of quality of care or a marker of a more severe disease with a worse prognosis? Eur Respir J (2016) 0.76
Prognostic role of D-dimer for in-hospital and 1-year mortality in exacerbations of COPD. Int J Chron Obstruct Pulmon Dis (2016) 0.75
The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trial. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Prognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPD. Int J Chron Obstruct Pulmon Dis (2015) 0.75
Sarcoidosis in an Italian province. Prevalence and environmental risk factors. PLoS One (2017) 0.75